View Post

CRISPR gene editing may halt progression of triple-negative breast cancer

In In The News by Barbara Jacoby

Source: Boston Children’s Hospital From: eurekalert.org A tumor-targeted CRISPR gene editing system, encapsulated in a nanogel and injected into the body, could effectively and safely halt the growth of triple-negative breast cancer, report researchers at Boston Children’s Hospital. Their proof-of-principle study, conducted in human tumor cells and in mice, suggests a potential genetic treatment for triple-negative breast cancer, which has …

View Post

Targeting triple-negative breast cancer with new drug design

In In The News by Barbara Jacoby

By: Laura Castañón, Northeastern University From: medicalxpress.com The type of breast cancer most likely to affect young people and African Americans is also one of the most aggressive and difficult to treat. Triple-negative breast cancer, which represents about 20 percent of all breast cancer cases, is named for its lack of three common hormone receptors. Since targeted breast cancer treatments …

View Post

Living color: Rainbow-hued blood stem cells shed new light on cancer, blood disorders

In In The News by Barbara Jacoby

Journal reference: Nature Cell Biology From: phys.org A new color-coding tool is enabling scientists to better track live blood stem cells over time, a key part of understanding how blood disorders and cancers like leukemia arise, report researchers in Boston Children’s Hospital’s Stem Cell Research Program. In Nature Cell Biology they describe the use of their tool in zebrafish to …